Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-25 @ 3:52 AM
NCT ID:
NCT01660802
Eligibility Criteria:
Inclusion Criteria:
-Presence of macular edema defined as macular thickening involving the center of the macula due to branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO)
Exclusion Criteria:
* History of glaucoma, ocular hypertension or optic nerve head change
* Any active bacterial, viral, parasitic, or fungal infections in either eye
* Eye surgery, including cataract surgery, and/or laser of any type in the study eye within 3 months prior to study start
* History of use of intravitreal steroids or any intravitreal injectable drug in the study eye within 3 months prior to study start
* Use of oral, intravenous, intramuscular, epidural, rectal, or extensive dermal steroids within 1 month prior to study start
* Use of immunosuppressants, immunomodulators, antimetabolites, and/or alkylating agents within 3 months prior to study start
* Use of topical ophthalmic corticosticosteroids within 2 weeks of study start
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT01660802
Study Brief:
Protocol Section:
NCT01660802